Fluorine-19 magnetic resonance angiography of the mouse

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  van Heeswijk, Ruud B ^a,b   Pilloud, Yves ^b,c   Flögel, Ulrich ^d   Schwitter, Jürg ^a   Stuber, Matthias ^a,b  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b University of Lausanne   (Switzerland)

^c EPFL   (Switzerland)

^d HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORINE; FLUOROCARBON; PERFLUORO 15 CROWN 5 ETHER; UNCLASSIFIED DRUG;

ACCURACY; ANATOMY; ANIMAL EXPERIMENT; ARTICLE; BLOOD ANALYSIS; BLOOD LEVEL; CONTRAST TO NOISE RATIO; CONTROLLED STUDY; EMULSION; FEASIBILITY STUDY; FLUORINE NUCLEAR MAGNETIC RESONANCE; IMAGE DISPLAY; IMAGE PROCESSING; IN VITRO STUDY; IN VIVO STUDY; LIMIT OF DETECTION; LIVER BLOOD VESSEL; LIVER PARENCHYMA; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MOUSE; NONHUMAN; PROTON NUCLEAR MAGNETIC RESONANCE; RADIOLOGICAL PARAMETERS; SIGNAL NOISE RATIO; VENOUS BLOOD;

ANIMALS; CROWN ETHERS; FLUORINE; INJECTIONS, INTRAVENOUS; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MICE; MICE, INBRED BALB C;

ANIMALIA; MUS;

EID: 84864411248     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0042236     Document Type: Article

References (19)

1. Bluemke DA, Achenbach S, Budoff M, Gerber TC, Gersh B, et al.((2008)) Noninvasive coronary artery imaging: magnetic resonance angiography and multidetector computed tomography angiography: a scientific statement from the american heart association committee on cardiovascular imaging and intervention of the council on cardiovascular radiology and intervention, and the councils on clinical cardiology and cardiovascular disease in the young. Circulation 118:: 586--606.
2. Lewis M, Yanny S, Malcolm PN,((2012)) Advantages of blood pool contrast agents in MR angiography: A pictorial review. J Med Imaging Radiat Oncol 56:: 187--191.
3. Gerretsen SC, le Maire TF, Miller S, Thurnher SA, Herborn CU, et al.((2010)) Multicenter, double-blind, randomized, intraindividual crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine for MR angiography of peripheral arteries. Radiology 255:: 988--1000.
4. Holland GN, Bottomley PA, Hinshaw WS,((1977)) 19F magnetic resonance imaging. J Magn Reson 28:: 133--136.
5. Riess JG,((2006)) Perfluorocarbon-based oxygen delivery. Artif Cells Blood Substit Immobil Biotechnol 34:: 567--580.
6. Joseph PM, Fishman JE, Mukherji B, Sloviter HA,((1985)) In vivo 19F NMR imaging of the cardiovascular system. J Comput Assist Tomogr 9:: 1012--1019.
7. Neubauer AM, Caruthers SD, Hockett FD, Cyrus T, Robertson JD, et al.((2007)) Fluorine cardiovascular magnetic resonance angiography in vivo at 1.5 T with perfluorocarbon nanoparticle contrast agents. J Cardiovasc Magn Reson 9:: 565--573.
8. Korosoglou G, Shah S, Vonken EJ, Gilson WD, Schar M, et al.((2008)) Off-resonance angiography: a new method to depict vessels-phantom and rabbit studies. Radiology 249:: 501--509.
9. Flogel U, Ding Z, Hardung H, Jander S, Reichmann G, et al.((2008)) In vivo monitoring of inflammation after cardiac and cerebral ischemia by fluorine magnetic resonance imaging. Circulation 118:: 140--148.
10. Watts R, Wang Y,((2002)) k-space interpretation of the Rose Model: noise limitation on the detectable resolution in MRI. Magn Reson Med 48:: 550--554.
11. Spees WM, Gade TP, Yang G, Tong WP, Bornmann WG, et al.((2005)) An 19F magnetic resonance-based in vivo assay of solid tumor methotrexate resistance: proof of principle. Clin Cancer Res 11:: 1454--1461.
12. Etienne A, Botnar RM, Van Muiswinkel AM, Boesiger P, Manning WJ, et al.((2002)) "Soap-Bubble" visualization and quantitative analysis of 3D coronary magnetic resonance angiograms. Magn Reson Med 48:: 658--666.
13. Eger EI 2nd, Saidman LJ,((2005)) Illustrations of inhaled anesthetic uptake, including intertissue diffusion to and from fat. Anesth Analg 100:: 1020--1033.
14. Keipert PE,((1995)) Use of Oxygent, a perfluorochemical-based oxygen carrier, as an alternative to intraoperative blood transfusion. Artif Cells Blood Substit Immobil Biotechnol 23:: 381--394.
15. Morawski AM, Winter PM, Yu X, Fuhrhop RW, Scott MJ, et al.((2004)) Quantitative "magnetic resonance immunohistochemistry" with ligand-targeted (19)F nanoparticles. Magn Reson Med 52:: 1255--1262.
16. Giraudeau C, Flament J, Marty B, Boumezbeur F, Meriaux S, et al.((2010)) A new paradigm for high-sensitivity 19F magnetic resonance imaging of perfluorooctylbromide. Magn Reson Med 63:: 1119--1124.
17. Mattrey RF, Long DM, Multer F, Mitten R, Higgins CB,((1982)) Perfluoroctylbromide: a reticuloendothelial-specific and tumor-imaging agent for computed tomography. Radiology 145:: 755--758.
18. D'Ambra MN, Kaplan DK,((1995)) Alternatives to allogeneic blood use in surgery: acute normovolemic hemodilution and preoperative autologous donation. Am J Surg 170:: 49S--52S.
19. Hu L, Chen J, Yang X, Caruthers SD, Lanza GM, et al. Evaluating Endothelial Damage in Acute Kidney Injury with Perfluorocarbon (PFC) Nanoparticles (NP) and 19F MRI; 2012; Melbourne, Australia.